1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid, 98%, 100mg

tert-Butyldimethyl(1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropoxy)silane, 250mg

4-Methoxy-3-(trifluoromethyl)phenylboronic Acid (contains varying amounts of Anhydride)200mg

6-Hydroxy-4-methylpyridin-2(1H)-one, 95.0%, 25g

2-Propyl-2,3-dihydro-1H-inden-1-one, 97%, 5g

Solution standard ICP de tungstène, ROTI®Star, 10000 mg/l W, densité (D) 1 g/cm³

3-Chloro-2,5-dimethoxypyridine, 97%, 500mg

3,5-Dichloro-N-methylaniline, 98.0%, 5g

(R)-(+)-DBD-Pro-COCl [=(R)-(+)-4-(N,N-Dimethylaminosulfonyl)-7-(2-chloroformylpyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for e.e. Determination]>95.0%(HPLC)100mg

3-(3-(furan-2-yl)-1,2,4-oxadiazol-5-yl)propan-1-amine hydrochloride, 95.0%, 250mg

2,4-dimethyl-2'-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone, 97.0%, 1g

Tert-butyl 5-bromofuran-2-carboxylate, 98%, 250mg

1-(2-methylpropyl)-1H-pyrazol-4-amine, 95.0%, 100mg